Search Results for "Breast Pap Test Trial"

08:40 EST 20th December 2014 | BioPortfolio

Original Source: NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination and/or differentiation of normal versus pre-malignant versu...

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Blood Test for Breast Cancer

It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early. A team, led by Oxford University scientists, took te...

New Test Predicts Which Early Breast Cancer Will Metastasize

A test that predicts breast cancer metastases may not be too far away. Unlike other panels, this test checks for the three-cell structure found at sites of extravasation. Medscape Medical News

Blood Test for Predicting Breast Cancer

A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer A simple blood test is currently in development that could help predict the l...

FDA Master Protocol In Metastatic Breast Cancer Likely In The Works

Oct. 21 public workshop cosponsored by prominent oncology groups will discuss international genomically driven trial to test multiple agents in metastatic breast cancer.

[News] Epigenetic test for breast cancer

A new study has identified a blood-based epigenetic signature associated with breast cancer risk and mortality. The findings show the potential for an epigenetic test that could eventually be used to...

Breast cancer warning from blood test

Women with a predisposition to breast cancer could be warned of developing symptoms by a simple blood test even if they do not inherit genes associated with disease, scientists said on Friday. Researc...

Breast cancer risk test 'promising'

A simple blood test could offer many women an early warning of breast cancer even if they do not inherit genes linked to the disease.

Gene Test May Help Predict Return of Early Breast Tumor, Study Says

FRIDAY, Dec. 12, 2014 -- For women who have early breast tumors surgically removed, a new genetic test may help predict the odds of a recurrence, a new study says. The research, presented Friday at th...

Matching PubMed Articles

The influence of chlorella and its hot water extract supplementation on quality of life in patients with breast cancer.

A self-control, randomized, and open-label clinical trial was performed to test the effects of the unicellular green algae Chlorella and hot water extract supplementation on quality of life (QOL) in p...

Positive Results for Drug Combo in I-SPY 2 Trial.

In results from one part of the I-SPY 2 trial announced at the 2013 San Antonio Breast Cancer Symposium, neoadjuvant veliparib plus carboplatin improved outcomes for women with triple-negative breast ...

Contralateral Prophylactic Mastectomy in the American College of Radiology Imaging Network 6667 Trial: Effect of Breast MR Imaging Assessments and Patient Characteristics.

Purpose To assess which patient and magnetic resonance (MR) imaging factors are associated with the likelihood of contralateral prophylactic mastectomy (CPM) in patients with newly diagnosed breast ca...

Prospective Cohort Study: Whether or Not Patients Benefit from Participation Itself in Randomized-controlled Trials (SELECT BC ECO).

The randomized-controlled trial is widely accepted as a clinical trial to decide a standard therapy. It remains to be concluded whether or not patients benefit from participation itself in a randomize...

A novel targeted therapy in breast cancer: Cyclin dependent kinase inhibitors.

Breast cancer is the most common cancer in women worldwide. Understanding the biology of this tumor is a prerequisite for selecting an appropriate treatment. Cell cycle alterations are seen in many ca...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement